Debbie Lin
Executive Director @ Boehringer Ingelheim Venture Fund
Cambridge, United States
Debbie Lin is a Series A investor at Boehringer Ingelheim Venture Fund in Cambridge focused on Biotechnology and Medical Device. Debbie Lin, Investor and Executive Director at Boehringer Ingelheim Venture Fund.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Debbie Lin invests in
Stages Debbie Lin invests in
Countries Debbie Lin invests in
Investment Focus
Industry
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Optina Diagnostics
|
Optina Diagnostics develops technology for the early detection of disease through the eye. | $20.1M / Series A / Oct 28, 2021 |
Co-Investors
About Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Boehringer Ingelheim Venture Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Debbie Lin
Executive Director
|
|||
Knut Elbers
Project Manager
|
|||
Martin Heidecker
Managing Director
|
|||
Oliver Reuss
Executive Director and Investment Manager
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Debbie Lin invest in?
Debbie Lin invests primarily in Biotechnology and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Debbie Lin last invest?
The most recent investment recorded for Debbie Lin closed in Oct 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
